surpass 4 tirzepatide Lilly's achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial Tirzepatide Matches Dulaglutide in Large

A brand-new systematic review just hit the journals, and its the most comprehensive look weve seen yet at the mechanism, the MSK outcomes, and the massive safety gray areas surrounding this compound

Lateef OM, Akintubosun MO

Weight stigma is linked to poorer mental health, so it is unsurprising that Ozempic users experiencing weight loss may experience improved mood

Keep a symptom log noting when discomfort occurs relative to meals, injections, and activitythis information helps your PlexusDx provider refine your regimen

Compounded semaglutide contains semaglutide, but it is not the FDA-approved finished product Wegovy or Ozempic

At the average 231-lb starting weight used in Phase 2 trials, a 24.2% weight loss equals approximately 56 lbs